Marella Thorell - 21 Mar 2022 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief Accounting Officer
Signature
/s/ Marella Thorell
Issuer symbol
CNTA
Transactions as of
21 Mar 2022
Net transactions value
$0
Form type
4
Filing time
23 Mar 2022, 16:56:30 UTC
Previous filing
03 Feb 2022
Next filing
10 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNTA Ordinary Shares Other $0 +52,101 +5210% $0.000000 53,101 21 Mar 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares ("ADSs"), each of which currently represents one Ordinary Share.
F2 Represents ADSs received by the Reporting Person, for no consideration, pursuant to contingent value rights granted to the Reporting Person in January 2021.